Search Results - "Çaglayan, Çaglar"
-
1
Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator Based on Discrete-Event Simulations
Published in Frontiers in public health (28-01-2022)“…The COVID-19 pandemic has significantly stressed healthcare systems. The addition of monoclonal antibody (mAb) infusions, which prevent severe disease and…”
Get full text
Journal Article -
2
A population‐based multistate model for diffuse large B‐cell lymphoma–specific mortality in older patients
Published in Cancer (01-06-2019)“…Background Despite effective therapies, outcomes for diffuse large B‐cell lymphoma (DLCBL) remain heterogeneous in older individuals due to comorbid diseases…”
Get full text
Journal Article -
3
Enhancing the Management of Deployment-Limiting Medical Conditions in the U.S. Department of Navy Leveraging Electronic Health Records and Predictive Analytics Methods
Published in Military medicine (19-08-2024)“…Deployment-limiting medical conditions (DLMCs) such as debilitating injuries and conditions may interfere with the ability of military service members (SMs) to…”
Get full text
Journal Article -
4
A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms
Published in Frontiers in public health (17-03-2022)“…The rising prevalence of multi-drug resistant organisms (MDROs), such as Methicillin-resistant (MRSA), Vancomycin-resistant (VRE), and Carbapenem-resistant…”
Get full text
Journal Article -
5
Prognostic value of sst2 in long-term mortality in acute heart failure
Published in Acta Cardiologica (24-09-2024)“…The use of biochemical markers in ADHF is considered valuable both in the diagnosis and treatment of diseases and in follow-up. This study aimed to investigate…”
Get full text
Journal Article -
6
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model
Published in Clinical lymphoma, myeloma and leukemia (01-05-2019)“…Disease progression within < 2 years of initial chemoimmunotherapy and patient age > 60 years have been associated with poor overall survival (OS) in…”
Get full text
Journal Article -
7
Microsimulation Modeling in Oncology
Published in JCO clinical cancer informatics (01-12-2018)“…Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the…”
Get more information
Journal Article -
8
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
Published in Clinical lymphoma, myeloma and leukemia (01-11-2022)“…Leveraging the Follicular Lymphoma Analysis of Surrogacy Hypothesis database of individual patient data from first-line clinical trials, we studied the…”
Get full text
Journal Article -
9
Riociguat Use in a Patient with Sickle Cell Anemia Related Chronic Thromboembolic Pulmonary Hypertension
Published in Turkish Thoracic Journal (09-09-2019)“…Introduction: Chronic thromboembolic pulmonary hypertension is a devastating complication of sickle cell anemia and it has limited treatment options. Riociguat…”
Get full text
Journal Article -
10
Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
Published in Kidney & blood pressure research (01-01-2015)“…Background/Aims: Contrast induced nephropathy (CIN) has multifactorial etiopatogenesis including oxidative stress and vasoconstriction. Nebivolol is an…”
Get full text
Journal Article -
11
Case images: A congenital contractile left ventricular diverticulum in the apex
Published in Türk Kardiyoloji Derneği arşivi (01-01-2009)Get full text
Journal Article -
12
A Multi-State Model for Senior Patients with Diffuse Large B Cell Lymphoma
Published in Blood (08-12-2017)“…Introduction: Diffuse large B-cell lymphoma (DLCBL) is the most common lymphoid malignancy in the United States. The combination of rituximab,…”
Get full text
Journal Article -
13
Abstract 15653: Optimizing the Screening Algorithm for Critical Congenital Heart Disease: A Data-Driven Approach
Published in Circulation (New York, N.Y.) (10-11-2015)“…IntroductionScreening for critical congenital heart disease (CCHD) using pulse oximetry is performed with various algorithms in the United States, with none of…”
Get full text
Journal Article -
14
A Multi-State Model for Follicular Lymphoma in Patients with Early Progression to Second Line Therapy
Published in Blood (08-12-2017)“…Introduction: Follicular Lymphoma (FL) is the second most frequent lymphoma subtype, with a rapidly increasing incidence rate. Progression of disease within…”
Get full text
Journal Article -
15
Predicting Vancomycin-Resistant Enterococci (VRE) and Carbapenem-Resistant Organism (CRO) Colonization in the Intensive Care Unit
Published in Infection control and hospital epidemiology (01-10-2020)“…Background: Rapidly identifying patients colonized with multidrug-resistant organisms (MDROs) upon ICU admission is critical to control and prevent the spread…”
Get full text
Journal Article -
16
A multistate model for follicular lymphoma (FL) patients (pts) who experience early progression
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e18164 Background: FL is the second most frequent lymphoma subtype. Approximately 20% of FL pts experience disease progression within two years…”
Get full text
Journal Article -
17
Team Based, Risk Adjusted Staffing During a Pandemic: An Agent Based Approach
Published in 2020 Winter Simulation Conference (WSC) (14-12-2020)“…Since the World Health Organization declared the novel coronavirus disease a pandemic, more than 2 million cases of infections and 140,000 deaths have been…”
Get full text
Conference Proceeding -
18
A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
Published in BLOOD (13-11-2019)“…Introduction: Most patients with newly diagnosed FL treated with rituximab (R) alone or R + chemotherapy will experience prolonged progression-free survival…”
Get full text
Journal Article Conference Proceeding -
19